CPC A61K 31/517 (2013.01) [A61K 9/0019 (2013.01); A61K 31/337 (2013.01); A61K 47/62 (2017.08); A61P 35/00 (2018.01); C07K 16/2827 (2013.01); A61K 45/06 (2013.01)] | 26 Claims |
1. A method of treating metastatic triple negative breast cancer (MTNBC) in a patient having MTNBC, the method comprising administering to the patient a combination therapy comprising:
ipatasertib;
(ii) atezolizumab; and
(iii) paclitaxel or nab-paclitaxel,
wherein said combination therapy is administered over a 28-day cycle.
|